FOLH1 and posterior cortical atrophy: Indeed, in a recent study by Bauckneht et al. [42], different imaging modalities were shown to significantly influence the outcomes of a cohort of 402 oligorecurrent PCa patients undergoing MDT: specifically, 68Ga-PSMA-11 PET/CT-guided MDT demonstrated longer PFS (HR: 0.51, 95% CI: 0.26–1.00) and PFS2 (HR: 0.24, 95% CI: 0.09–0.60) compared to 18F-PSMA-1007 PET/CT-guided MDT, as well as longer PFS, PFS2, and OS compared to choline-PET/CT-guided MDT.